M11: A Tropism-modified Oncolytic Adenovirus Arming with Tumor-homing Peptide for Advanced Ovarian Cancer Therapies.

M11: A Tropism-modified Oncolytic Adenovirus Arming with Tumor-homing Peptide for Advanced Ovarian Cancer Therapies.
复制标题

M11:一种趋向性修饰的溶瘤腺病毒,配备肿瘤归巢肽,用于晚期卵巢癌治疗。

DOI:
10.1089/hum.2021.247
复制
发表时间:
2022-01
期刊:
影响因子:
4.2
通讯作者:
Gao Qinglei
Gao Qinglei
中科院分区:
医学2区
文献类型:
--
作者:
Li Fei;Yuan Yuan;Dai Yun;Cheng Teng;Cao Heng;Yan Dan-Mei;Li Ying;Sun Qian;Huang Xiao-Yuan;Gao Qinglei

文献摘要

参考文献

相似文献

溶瘤腺病毒(OAds)在癌症治疗中显示出巨大的前景,但其疗效受到肿瘤选择性差和高度脱靶肝脏隔离的极大限制。在此,我们产生了一种新的“隐形”和肿瘤靶向溶瘤剂,
Oncolytic adenoviruses (OAds) have shown great promise in cancer therapy, but their efficacy has been greatly limited by poor tumor selectivity and highly off-target liver sequestration. Herein, we generate a novel "stealth' and tumor-targeting oncolytic
DOI: 10.3892/or.2014.3065
发表时间: 2014-05
期刊: Oncology reports
影响因子: 4.2
作者:
Dongyang Wang;Wenbo Li;Hang Zhang;Q. Mao;Haibin Xia
通讯作者: Dongyang Wang;Wenbo Li;Hang Zhang;Q. Mao;Haibin Xia
DOI: 10.1182/blood-2006-04-008532
发表时间: 2006-10-15
期刊: BLOOD
影响因子: 20.3
作者:
Parker, Alan L.;Waddington, Simon N.;Baker, Andrew H.
通讯作者: Baker, Andrew H.
DOI: 10.1016/j.apsb.2016.08.005
发表时间: 2017-01
期刊: Acta pharmaceutica Sinica. B
影响因子: --
作者:
Deng J
通讯作者: Deng J
DOI: 10.1016/j.virol.2017.10.005
发表时间: 2018-01-15
期刊: Virology
影响因子: 3.7
作者:
Nguyen TV;Anguiano-Zarate SS;Matchett WE;Barry ME;Barry MA
通讯作者: Barry MA
DOI: 10.1038/mt.2011.71
发表时间: 2011-07-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Khare, Reeti;May, Shannon M.;Barry, Michael A.
通讯作者: Barry, Michael A.